logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Nanomaterials And Neoplasms Towards Clinical Applications Valerio Voliani

  • SKU: BELL-46150430
Nanomaterials And Neoplasms Towards Clinical Applications Valerio Voliani
$ 31.00 $ 45.00 (-31%)

4.4

22 reviews

Nanomaterials And Neoplasms Towards Clinical Applications Valerio Voliani instant download after payment.

Publisher: Jenny Stanford Publishing
File Extension: PDF
File size: 65.92 MB
Pages: 826
Author: Valerio Voliani
ISBN: 9789814800396, 9814800392
Language: English
Year: 2021

Product desciption

Nanomaterials And Neoplasms Towards Clinical Applications Valerio Voliani by Valerio Voliani 9789814800396, 9814800392 instant download after payment.

Nanomaterials have the potential to shift the paradigm for the diagnosis and treatment of many diseases, especially neoplasms, because of the intriguing behaviors associated with their unique size-/shape-influenced chemical, physical, and physiological features. Currently, there is a huge imbalance between the several nanoplatforms reported in the literature and the few ones approved for clinical applications. This disequilibrium affects, in particular, plasmonic nanomaterials, which present no approved platforms and few candidates in clinical trials. This trend can be reversed by promoting collaborations among scientists from different fields as well as by improving the multidisciplinary background of researchers interested in this area.

Related Products